NCT07242352
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07242352
Title Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC (ADAPTela)
Acronym ADAPTela
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors West German Study Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Brustzentrum Niederrhein, Johanniter Bethesda Krankenhaus RECRUITING Mönchengladbach North Rhine-Westphalia 41061 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field